Video: Alzheimer’s and the disappointing history of amyloid research

alzheimer’s
Image: Roche

The idea that sticky brain plaques cause Alzheimer’s disease began as an interesting hypothesis and eventually became drug industry dogma. Now, after a string of clinical trial failures, that hypothesis looks less credible than ever.

But how did nearly two decades of failure not convince the brightest minds in pharma that it was time to move on?

The answers are a little complicated.

Join us for a brief journey through the history of Alzheimer’s research to understand why the amyloid hypothesis — the one that suggests targeting those plaques could treat the disease — proved so persistent in the face of almost constant disappointment.

Related article:  First attempt at using CRISPR to edit genes inside the body targets inherited form of blindness

We start with Alois Alzheimer’s turn-of-the-century discovery that such plaques were present in the brain of a woman with early-onset dementia. Then we cut to the 1990s, when the drug industry advanced its first big amyloid idea: a vaccine that would turn the body’s defenses against the offending plaque.

Now, with the latest and arguably best amyloid-targeting therapy deemed a failure, the industry may at last be moving away from that approach to Alzheimer’s, having learned a series of hard lessons along the way.

Read full, original post: Watch: How did the amyloid hypothesis go from promising to perilous in the search for Alzheimer’s treatments?

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Video: Test everyone – Slovakia goes its own way to control COVID

Video: Test everyone – Slovakia goes its own way to control COVID

As Europe sees record coronavirus cases and deaths, Slovakia is testing its entire adult population. WSJ's Drew Hinshaw explains how ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
globalmethanebudget globalcarbonproject cropped x

Infographic: Cows cause climate change? Agriculture scientist says ‘belching bovines’ get too much blame

A recent interview by Caroline Stocks, a UK journalist who writes about food, agriculture and the environment, of air quality ...
organic hillside sweet corn x

Organic v conventional using GMOs: Which is the more sustainable farming?

Many consumers spend more for organic food to avoid genetically modified products in part because they believe that “industrial agriculture” ...
benjamin franklin x

Are most GMO safety studies funded by industry?

The assertion that biotech companies do the research and the government just signs off on it is false ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies for tighter GMO legislation and famously puts out annual "dirty dozen" list of fruits and ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be the prime mover behind the ongoing campaign against agricultural biotechnology at Consumer Reports. He is an ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend